Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2015 Oct 2;233(1):89–97. doi: 10.1007/s00213-015-4091-y

Table 2.

Principal components analysis (PCA) of acute AMPH-related subjective-effect measures (N=97)

Factor1 Positive Mood Factor2 Arousal Factor3 Drug High
DEQ
    Feel −.280 −.025 .905
    Like .383 .089 .45l
    High .123 −.040 .808
    More .382 −.089 .45l
ARCI
    A .092 .592 .325
    BG −.034 .862 .119
    MBG .464 .327 .249
    PCAG −.098 −.842 .113
POMS
    Arousal .367 .634 −.094
    Elation .983 −.012 −.066
    Fatigue .127 −.865 .145
    Friendliness .94l −.104 −.031
    Pos. Mood .890 .053 −.004
    Vigor .780 .110 .010

DEQ = Drug Effects Questionnaire

ARCI = Addiction Research Center Inventory (A=Amphetamine scale; BG=Benzedrine Group; MBG= Morphine-Benzedrine Group; PCAG= Pentobarbital-Chlorpromazine-Alcohol Group)

POMS = Profile of Mood States Questionnaire

Bolded factor loadings indicate the items that were used to calculate factor scores.

Subjective-effect scales that were not significantly altered by AMPH were not included in the PCA.